Skip to search formSkip to main contentSkip to account menu

nipradilol

Known as: 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate, 3,4-dihydro-8-(2-hydroxy-3--isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Purpose:  To prospectively study prognostic factors for normal‐tension glaucoma (NTG) under treatment with topical β‐blocker. 
Highly Cited
2009
Highly Cited
2009
PURPOSE Oxidative stress plays an important role in pathogenesis of glaucoma. The purpose of this study is to investigate the… 
2005
2005
The present study was performed to evaluate the intraocular pressure (IOP)-lowering effect of nipradilol in combination with… 
Highly Cited
2002
Highly Cited
2002
Purpose. To determine whether nipradilol, a new antiglaucoma drug, can protect retinal ganglion cells (RGCs) from secondary cell… 
Highly Cited
2002
Highly Cited
2002
PURPOSE To investigate the effects of topical nipradilol on blood velocity in the optic nerve head (ONH) in normal humans and the… 
Highly Cited
2001
Highly Cited
2001
PURPOSE To investigate the effect of nipradilol, an alpha(1),beta-blocker with a nitric oxide donative action, on N:-methyl-D… 
1996
1996
The effects of nipradilol, an ocular hypotensive drug, on isolated canine retinal central arteries and on retinal arterioles in…